Navigation Links
Vanrx Pharmasystems comes to Interphex 2017 with growing momentum for its Aseptic Filling Workcells
Date:3/14/2017

VANCOUVER, March 14, 2017 /PRNewswire/ - Vanrx Pharmasystems comes to exhibit at Interphex 2017 with growing adoption of its SA25 Aseptic Filling Workcell. The system is the first gloveless robotic isolator for aseptic filling of injectable drug products.

Singota Solutions (Booth #1461) and AB Biotechnologies (Booth #1539) have each publicly announced their adoption of Vanrx's aseptic filling systems, with other U.S. and global installations also occurring this year. Consultations have occurred between Vanrx, customers and regulatory bodies, including the U.S. Food and Drug Administration (FDA), for use of the Vanrx SA25 in clinical and commercial production.

Continue Reading
The Vanrx SA25 Aseptic Workcell is the first gloveless robotic isolator for automated filling of injectable or lyophilized therapies. At Interphex 2017, Vanrx will be showing the SA25 in its unique virtual reality experience. The SA25 fills syringes, vials and cartridges, and has industry-leading decontamination and product changeover times. It is well-suited for the manufacture of targeted, smaller volume therapies that form an increasing portion of pharmaceutical companies’ revenues. (CNW Group/Vanrx Pharmasystems Inc.)
The Vanrx SA25 Aseptic Workcell is the first gloveless robotic isolator for automated filling of injectable or lyophilized therapies. At Interphex 2017, Vanrx will be showing the SA25 in its unique virtual reality experience. The SA25 fills syringes, vials and cartridges, and has industry-leading decontamination and product changeover times. It is well-suited for the manufacture of targeted, smaller volume therapies that form an increasing portion of pharmaceutical companies’ revenues....

"Vanrx is growing at a tremendous rate as the industry recognizes the value of the company's approach to flexible aseptic filling. This edition of Interphex is special because we have so much to share with companies that were waiting to see progress towards product and regulatory milestones," says Chris Procyshyn, CEO, Vanrx Pharmasystems.

Visitors to booth 3904 can see the SA25 Workcell in operation through the company's innovative virtual reality experience. Viewers go inside a real Workcell as robots perform the work of filling and closing nested, pre-sterilized vials.

Vanrx will also participate in the IPS technology tours for the first time as part of the "aseptic small-scale / modular technologies" segment on March 22 at 10 a.m. and 1 p.m.

The SA25 Aseptic Filling Workcell uses robotics to perform all material handling, filling and container closing activities. It was designed by pharmaceutical veterans who wanted to solve long-standing aseptic processing problems within conventional fill-finish systems. Their goal was to make the production of complex drug products easier and improve patient safety.

Key benefits of the SA25 Workcell include:

  • Flexibility to fill and close vials, syringes or cartridges with industry-leading quality.
  • Efficient production of multiple products through fast changeover and batch cycling times.
  • Shortens time to construct filling operations or add capacity through a standardized design.
  • Scale production through additional Workcells to support flexible manufacturing capacity.
  • Lowers costs by using less space and requiring fewer utilities than conventional systems.
  • Use of nested components and closures simplifies material handling and minimizes particle generation

About Vanrx Pharmasystems

Vanrx Pharmasystems makes the most technologically advanced sterile filling solutions for the pharmaceutical industry. Vanrx fill-finish machines use isolated robotics and machine vision to automate the packaging of injectable drugs into nested vials, syringes, or cartridges. The company was founded by pharmaceutical industry veterans to create the systems needed to make the next generation of innovative therapies. For more information, visit www.vanrx.com.


'/>"/>
SOURCE Vanrx Pharmasystems Inc.
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
2. CVSL Inc. Name Change Becomes Official
3. PharmaRoth Labs Welcomes Two Respected Physicians to Board of Advisors
4. Mirixa and PDX Establish Relationship to Improve Patient Outcomes
5. Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes
6. New Era in Medicine Comes to Arizona
7. CureMD Becomes the Exclusive Provider of 4,400 Mitochon Free EMR Users
8. FDA Approvals, Diversified Product Pipeline, Produce Sales Growth, and Positive Study Outcomes - Research Report on Boston Scientific, Zimmer, St. Jude, ResMed, and GenMark
9. Hal Sutton Becomes Spokesperson for Stryker Orthopaedics
10. New Data From Partners Center For Connected Health Demonstrates Wireless Mobile Technology Improves Patient Engagement, Outcomes
11. Permobil Becomes Premiere-Level Partner of The ALS Association; Will Offer Support for People Affected by Lou Gehrigs Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2018)... N.J. (PRWEB) , ... October 20, 2018 , ... Dr. ... Top Dentists for the fifth consecutive year under ‘Cosmetic and Restorative Dentistry’ which ... 140 top dentists across 21 counties listed on NJ Top dentist website. Dr. ...
(Date:10/18/2018)... , ... October 18, 2018 , ... ... and human services provider, will celebrate 30 years of service to New Yorkers ... Columbia University, hosted by Bevy Smith. , Harlem United will honor Soledad ...
(Date:10/18/2018)... ... October 18, 2018 , ... Ensurem, LLC, an innovative ... announced today the launch of the first 100 percent digital application for Medicare ... mission to streamline the insurance industry. , The e-application offers consumers the ease ...
Breaking Medicine Technology:
(Date:10/16/2018)... ... October 16, 2018 , ... ... for upstream, midstream and downstream operators today announces Total Train Comprehensive Release version ... release of critical system components focused on improving cybersecurity defense around turbomachinery. ...
(Date:10/16/2018)... ... 16, 2018 , ... Bastyr University is pleased announce that ... and Medicine’s (AIHM) Visionary Award for his passionate efforts in forging a new ... as AIHM’s recipient of the Visionary Award due to his tireless effort in ...
(Date:10/16/2018)... (PRWEB) , ... October 16, 2018 , ... ... 23-25, 2018 – Bethesda, MD, http://www.fdanews.com/fdainspectionssummit , The 13th Annual FDA ... year’s Inspections Summit that it sometimes feels difficult to keep up. The FDA ...
(Date:10/16/2018)... ... 16, 2018 , ... The months of training are over. The race has come and gone. ... like they were put through the wringer after the big event. Read on for something ... in Motion on how to treat the body and mind after a long run: , ...
(Date:10/13/2018)... ... October 12, 2018 , ... At HEI Health, we believe tomorrow’s healthcare ... attending this year’s National Healthcare CXO Fall Summit by Marcus Evans. HEI will be ... and Patient Experience challenges with leading healthcare providers. , Marcus Evans National Healthcare ...
Breaking Medicine News(10 mins):